Research and Markets has announced the addition of the "Global Molecular Diagnostics 2010-2016: Deal trends, players, financials and forecasts" report to their offering.

The Global Molecular Diagnostics Partnering 2010-2016 report provides a detailed understanding and analysis of how and why companies enter molecular diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

The report takes the reader through a comprehensive review Molecular Diagnostics deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Molecular Diagnostics partnering deals.

The report presents financial deal term values for Molecular Diagnostics deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

Key benefits

  • In-depth understanding of Molecular Diagnostics deal trends since 2010
  • Access to headline, upfront, milestone and royalty data
  • Analysis of the structure of Molecular Diagnostics agreements with numerous real life case studies
  • Detailed access to actual Molecular Diagnostics contracts entered into by leading biopharma companies
  • Identify most active Molecular Diagnostics dealmakers since 2010
  • Insight into terms included in a Molecular Diagnostics partnering agreement, with real world examples
  • Understand the key deal terms companies have agreed in previous deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

In Global Molecular Diagnostics Partnering 2010-2016: Deal trends, players, financials and forecasts, the available deals are listed by:

  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy target
  • Technology type

Key Topics Covered:

Executive Summary

Chapter 1 Introduction

Chapter 2 Trends in Molecular Diagnostics dealmaking

Chapter 3 Leading Molecular Diagnostics deals

Chapter 4 Most active Molecular Diagnostics dealmakers

Chapter 5 Molecular Diagnostics contracts dealmaking directory

Chapter 6 Molecular Diagnostics dealmaking by technology type

Chapter 7 Partnering resource center

For more information about this report visit http://www.researchandmarkets.com/research/sj92ws/global_molecular